Abstract CT148: A phase Ib study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors

Journal article

Peer reviewed

Colin Weekes, A Craig Lockhart, Heinz-Josef Lenz, James J Lee, Adriaan Cleton, Funan Huang and Isrid Sturm

Cancer research (Chicago, Ill.), Vol.76(14 Supplement), pp.CT148-CT148

2016-07-15

Metrics

2 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.111 Liver & Colon Cancer; 1.111.162 Hepatocellular Carcinoma
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Abstract CT148: A phase Ib study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors
Creators: Colin Weekes
A Craig Lockhart
Heinz-Josef Lenz
James J Lee
Adriaan Cleton
Funan Huang
Isrid Sturm
Publication Details: Cancer research (Chicago, Ill.), Vol.76(14 Supplement), pp.CT148-CT148
Academic Unit: Miller School of Medicine
Language: English
Resource Type: Journal article
Record Identifier: 991031598287802976